Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arich Enterprise CoROCO:4173 +0.29%70 EV-to-EBIT is 10.39 as of Sep. 08, 2026, which is 35% below its 10-year median of 15.94. GuruFocus rates ROCO:4173 with a GF Score™ of 70/100 and a GF Value™ of NT$28.07 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 474 Healthcare Providers & Services companies, Arich Enterprise Co ranks better than 71.31% on this metric.
The historical rank and industry rank for Arich Enterprise Co's EV-to-EBIT or its related term are showing as below:
ROCO:4173'
s EV-to-EBIT Range Over the Past 10 Years
Min: -22.34 Med: 15.94 Max: 103.12
Current: 10.39
During the past 13 years, the highest EV-to-EBIT of Arich Enterprise Co was 103.12. The lowest was -22.34. And the median was 15.94.
ROCO:4173's EV-to-EBIT is ranked better than 71.31% of 474
companies
in the Healthcare Providers & Services industry
Industry Median: 15.375
vs ROCO:4173: 10.39
Arich Enterprise Co (ROCO:4173) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Arich Enterprise Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$902 Mil.
Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co EV-to-EBIT Related Terms
Arich Enterprise Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Arich Enterprise Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co EV-to-EBIT Competitor Comparison
For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arich Enterprise Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Arich Enterprise Co's EV-to-EBIT falls into.
Arich Enterprise Co's current Enterprise Value is NT$842 Mil.
Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co (ROCO:4173) has a EV-to-EBIT of 10.39 as of Sep. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Arich Enterprise Co and its competitors. This is 35% below median its historical median of 15.94. According to the industry distribution chart, Arich Enterprise Co ranks #136 out of 474 companies in the Healthcare Providers & Services industry, placing it in the top 28.7%.
Is Arich Enterprise Co's EV-to-EBIT too high?
Arich Enterprise Co's current EV-to-EBIT of 10.39 is 35% below median its 10-year median of 15.94. The Healthcare Providers & Services industry median EV-to-EBIT is 15.38. Arich Enterprise Co's value of 10.39 is 32.4% below this industry median. Based on the distribution chart, Arich Enterprise Co ranks #136 out of 474 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Arich Enterprise Co has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arich Enterprise Co's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Arich Enterprise Co ranks #136 out of 474 companies for EV-to-EBIT. This puts Arich Enterprise Co in the upper half of its industry. The industry median EV-to-EBIT is 15.38. Arich Enterprise Co's value of 10.39 is 32.4% below this benchmark. While the company's 10-year median is 15.94 vs. the industry median of 15.38, Arich Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.38, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arich Enterprise Co's current EV-to-EBIT of 10.39 is 32.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Arich Enterprise Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arich Enterprise Co's current EV-to-EBIT is 10.39, which is 35% below median its own 10-year median of 15.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arich Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Arich Enterprise Co (ROCO:4173) is currently considered Possible Value Trap. The stock's GF Value™ is NT$28.07, compared to a current price of NT$17.15 — trading 38.9% below its estimated fair value. The current EV-to-EBIT is 10.39, which is 35% below median its 10-year median of 15.94 and 32.4% below the Healthcare Providers & Services industry median of 15.38. Arich Enterprise Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Arich Enterprise Co (ROCO:4173), the current EV-to-EBIT is 10.39 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arich Enterprise Co (ROCO:4173) Overvalued in 2026?
Based on GuruFocus' analysis, Arich Enterprise Co stock appears to be undervalued.
The current stock price of NT$17.15 is trading 38.9% below its estimated GF Value™ of NT$28.07.
GuruFocus considers Arich Enterprise Co to be Possible Value Trap.
Key valuation signals for ROCO:4173:
EV-to-EBIT: 10.39 (35% below median its 10-year median of 15.94)
GF Value™: NT$28.07 vs. price of NT$17.15 (38.9% below fair value)
Industry Position: 32.4% below the Healthcare Providers & Services median (#136 of 474)
No single metric tells the full story. See the ROCO:4173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
70GF Score
Get the complete analysis for ROCO:4173
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4173 has been successfully added to your 
